Skip to main content

Fiscal Wizard · Single-issue tearsheet

BLTE / Jun 21, 2026 Run #7475

BLTE

Belite Bio, Inc

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

Composite verdict

B 68.7 / 100
Bullish setup · Reversal 14 drivers · 3 gates blocking
  • Rate of Change
  • Parabolic SAR Flip
  • Declining Volume
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 36th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: volatile range
Bull 100%Evidence: High · 20 signals0% Bear
Momentum Bullish 83Mean-reversion Neutral 54

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -88%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

37.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Return on Assets 79
Margin of Safety 0
Return on Capital Employed 79
Forward P/E 0
Greenblatt ROC 78
Free Cash Flow Yield 0

Technicals Bullish

99.4 / 100

Bullish setup leads (Rate of Change, Parabolic SAR Flip, Declining Volume); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Rate of Change 94
Parabolic SAR Flip 88
Wedge Pattern 86

Risk Gates

3 blocking 5 caution

3 guards active, 20 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for BLTE.